Quick Answer
VERACYTE, INC. reported Total Revenue of $517.15 million for the year ending 2025.
- VERACYTE, INC. showed an increase of +16.0% in Total Revenue from 2024 to 2025.
- This data is from VERACYTE, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $16.43 million | Q2 2017: $18.41 million | Q3 2017: $17.52 million | Q3 2017: $17.52 million | Q4 2017: $19.60 million | Q1 2018: $20.04 million | Q2 2018: $22.75 million | Q3 2018: $23.47 million | Q3 2018: $23.47 million | Q4 2018: $25.75 million | Q1 2019: $29.53 million | Q2 2019: $30.14 million | Q3 2019: $30.97 million | Q4 2019: $29.73 million | Q1 2020: $31.12 million | Q2 2020: $20.70 million | Q3 2020: $31.12 million | Q4 2020: $34.54 million | Q1 2021: $36.70 million | Q2 2021: $55.11 million | Q3 2021: $60.37 million | Q1 2022: $67.78 million | Q2 2022: $72.86 million | Q3 2022: $75.59 million | Q1 2023: $82.42 million | Q2 2023: $90.32 million | Q3 2023: $90.11 million | Q1 2024: $96.84 million | Q2 2024: $114.43 million | Q3 2024: $115.86 million | Q1 2025: $114.47 million | Q2 2025: $130.16 million | Q3 2025: $131.87 million.
- Over the full 10 years of available data (2016 to 2025), VERACYTE, INC.'s Total Revenue has grown by 694.6%.
- Historical annual values: Fiscal year 2025: $517.15 million | Fiscal year 2024: $445.76 million | Fiscal year 2023: $361.05 million | Fiscal year 2022: $296.54 million | Fiscal year 2021: $219.51 million | Fiscal year 2020: $117.48 million | Fiscal year 2019: $120.37 million | Fiscal year 2018: $92.01 million | Fiscal year 2017: $71.95 million | Fiscal year 2016: $65.09 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: